Translational Development Acquisition Corp. (NASDAQ:TDACU) Short Interest Down 99.0% in June

Translational Development Acquisition Corp. (NASDAQ:TDACU) saw a significant decrease in short interest in June. As of June 15th, there was short interest totaling 1 shares, a decrease of 99.0% from the May 31st total of 96 shares. Based on an average trading volume of 2,417 shares, the short-interest ratio is currently 0.0 days.

Translational Development Acquisition Stock Performance

Shares of TDACU stock traded up $0.36 during mid-day trading on Thursday, hitting $12.36. 200 shares of the stock were exchanged, compared to its average volume of 3,408. The stock’s fifty day simple moving average is $11.42 and its two-hundred day simple moving average is $10.82. Translational Development Acquisition has a 12-month low of $10.71 and a 12-month high of $17.29.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.